CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-30 | Domzalski David President and CEO | Grant or award | +4,705 | $0.88 | $4K | 767,520 |
| 2021-09-30 | Zeronda Tyler Interim CFO | Shares withheld for taxes | −206 | $1.39 | $286 | 83,348 |
| 2021-09-30 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −1,480 | $1.39 | $2K | 155,129 |
| 2021-09-30 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −1,484 | $1.39 | $2K | 164,697 |
| 2021-09-30 | Domzalski David President and CEO | Shares withheld for taxes | −13,096 | $1.39 | $18K | 762,815 |
| 2021-09-02 | Zeronda Tyler Interim CFO | Grant or award | +60,859 | 83,554 | ||
| 2021-09-02 | Zeronda Tyler Interim CFO | Grant or award · Stock Options | +60,860 | 60,860 | ||
| 2021-09-02 | Stuart Iain Chief Scientific Officer | Grant or award | +60,859 | 156,609 | ||
| 2021-09-02 | Stuart Iain Chief Scientific Officer | Grant or award · Stock Options | +60,860 | 60,860 | ||
| 2021-09-02 | Harsch Mutya Chief Legal Officer and GC | Grant or award | +60,859 | 166,181 | ||
| 2021-09-02 | Harsch Mutya Chief Legal Officer and GC | Grant or award · Stock Options | +60,860 | 60,860 | ||
| 2021-09-02 | Domzalski David President and CEO | Grant or award | +320,312 | 775,911 | ||
| 2021-09-02 | Domzalski David President and CEO | Grant or award · Stock Options | +320,313 | 320,313 | ||
| 2021-08-25 | LEPORE PATRICK G Director | Purchase | +12,500 | $1.60 | $20K | 50,000 |
| 2021-08-16 | PERCEPTIVE ADVISORS LLC 10% owner | Sale | −250,000 | $1.74 | $435K | 4,935,057 |
| 2021-08-13 | PERCEPTIVE ADVISORS LLC 10% owner | Sale | −250,000 | $1.84 | $460K | 5,185,057 |
| 2021-08-12 | PERCEPTIVE ADVISORS LLC 10% owner | Sale | −338,897 | $2.23 | $756K | 5,435,057 |
| 2021-07-19 | Sandoval Elisabeth Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2021-07-19 | LEPORE PATRICK G Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2021-07-19 | Bruno Anthony D Director | Grant or award · Stock Options | +20,500 | 20,500 |
Page 9 of 22 · 425 trades